In Vitro Development of Human Killer–Immunoglobulin Receptor-Positive NK Cells

  • Frank Cichocki
  • Jeffrey S. Miller
Part of the Methods in Molecular Biology book series (MIMB, volume 612)


The in vitro culture system outlined in this chapter allows for the delineation of events that occur during the development of CD34+ hematopoietic precursor cells into mature KIR+ human NK cells. This system can also be utilized to study the effects of gene overexpression or knockdown on the process of NK cell differentiation through retroviral transduction and long-term culture. The necessary soluble factors and contact-dependent conditions for in vitro human NK cell development have been worked out in our laboratory over the past 16 years.

Key words

Human NK cell development lymphocyte differentiation from hematopoietic precursors 


  1. 1.
    Colucci, F., Caligiuri, M.A., and Di Santo, J.P. (2003) What does it take to make a natural killer? Nat. Rev. Immunol. 3, 413–425.CrossRefPubMedGoogle Scholar
  2. 2.
    Huntington, N.D., Vosshenrich, C.A., and Di Santo, J.P. (2007) Developmental pathways that generate natural-killer-cell diversity in mice and humans. Nat. Rev. Immunol. 7, 703–714.CrossRefPubMedGoogle Scholar
  3. 3.
    Kim, S., Iizuka, K., Kang, H.P., Dokun, A., French, A.R., Greco, A., and Yokoyama, W.M. (2002) In vivo developmental stages in murine natural killer cell development. Nat. Immunol. 3, 523–528.CrossRefPubMedGoogle Scholar
  4. 4.
    Freud, A.J., Yokohama, A., Becknell, A., Lee, M.T., Mao, H.C., Ferketich, A.K., and Caligiuri, M.A. (2006) Evidence for discrete stages of human natural killer cell differentiation in vivo. J. Exp. Med. 203, 1033–1043.CrossRefPubMedGoogle Scholar
  5. 5.
    Miller, J.S., Verfaille, C., and McGlave, P. (1992) The generation of human natural killer cells from CD34+/DR primitive progenitors in long-term bone marrow culture. Blood. 80, 2182–2187.PubMedGoogle Scholar
  6. 6.
    Miller, J.S., Alley, K.A., and McGlave, P. (1994) Differentiation of natural killer (NK) cells from human primitive marrow progenitors in a stroma-based long-term culture system: identification of a CD34+7+ NK progenitor. Blood. 9, 2594–2601.Google Scholar
  7. 7.
    Miller, J.S., McCullar, V., and Verfaillie, C.M. (1998) Ex vivo culture of CD34+/Lin/DR cells in stroma-derived soluble factors, interleukin-3, and macrophage inflammatory protein-1α maintains not only myeloid but also lymphoid progenitors in a novel switch culture assay. Blood. 12, 4516–4522.Google Scholar
  8. 8.
    Miller, J.S., and McCullar, V. (2001) Human natural killer cells with polyclonal lectin and immunoglobulinlike receptors develop from single hematopoietic stem cells with preferential expression of NKG2A and KIR2DL2/L3/S2. Blood. 98, 705–713.CrossRefPubMedGoogle Scholar
  9. 9.
    McCullare, V., Oostendorp, R., Panoskaltsis-Mortari, A., Yun, G., Lutz, C.T., Wagner, J.E., and Miller, J.S. (2008) Mouse fetal and embryonic liver cells differentiate human umbilical cord blood progenitors into CD56-negative natural killer cell precursors in the absence of interleukin-15. Exp. Hematol. 36, 598–608.CrossRefGoogle Scholar
  10. 10.
    Grzywacz, B., Kataria, N., Sikora, M., Oostendorp, R.A., Dzierzak, E.A., et al. (2006) Coordinated acquisition of inhibitory and activating receptors and functional properties by developing human natural killer cells. Blood. 108, 3824–3833.CrossRefPubMedGoogle Scholar
  11. 11.
    Yu, H., Fehniger, T.A., Fuchshuber, P., Thiel, K.S., Vivier, E., et al. (1998) Flt3 ligand promotes the generation of a distinct CD34+ human natural killer cell progenitor that responds to interleukin-15. Blood. 92, 3647–3657.PubMedGoogle Scholar
  12. 12.
    Cooley, S., Xiao, F., Pitt, M., Gleason, M., McCullar, V. et al. (2007) A subpopulation of human peripheral blood NK cells that lacks inhibitory receptors for self-MHC is developmentally immature. Blood. 110, 578–586.CrossRefPubMedGoogle Scholar
  13. 13.
    Nakayama, N., Fang, I., and Elliott, G. (1998) Natural killer and B-lymphoid potential in CD34+ cells derived from embryonic stem cells differentiated in the presence of vascular endothelial growth factor. Blood. 1, 2283–2295.Google Scholar
  14. 14.
    Giarratana, M.C., Verge, V., Schmitt, C., Tertho, J.M., et al. (2000) Presence of primitive lymphoid progenitors with NK or B potential in ex vivo expanded bone marrow cell cultures. Exp. Hematol. 28, 46–54.CrossRefPubMedGoogle Scholar
  15. 15.
    Chiorean, E.G., Dylla, S., Olsen, K., Lenvik, T., Soignier, Y., et al. (2003) BCR/ABL alters the function of NK cells and the acquisition of killer immunoglobulin-like receptors (KIR). Blood. 101, 3327–3533.CrossRefGoogle Scholar

Copyright information

© Humana Press, a part of Springer Science+Business Media, LLC 2010

Authors and Affiliations

  • Frank Cichocki
    • 1
  • Jeffrey S. Miller
    • 1
  1. 1.University of Minnesota Cancer CenterMinneapolisUSA

Personalised recommendations